IONS Ionis Pharma: Margin dodolan resik

ionispharma.com (IONS) - logo korporat

Ionis Pharmaceuticals management is transforming its strategy by shifting toward direct sales supported by investments in science. The company's net margin ratio demonstrates the effectiveness of this path, where the -56.90 level indicates the status of the parameter. Licensing technologies to industry behemoths creates powerful leverage by eliminating distribution costs, while financial stability relies on royalties and the success of clinical trials for new drugs.

ionispharma.com (IONS) - Margin resik saka 04.07.2022 nganti 19.11.2026

Ionis Pharma - rincian analitis lan metrik utama (IONS)

- rega saham lan prakiraan rega para ahli:
Analisis kabeh metrik perusahaan:Ionis Pharmaceuticals, Inc. - IONS
Produk dadi Ionis Pharmaceuticals, Inc.

Net profit margin measures the portion of profit remaining from revenue after deducting all operating and financial expenses, determining the efficiency of cost management. By analyzing the final sales margin, an investor assesses the ability of Ionis Pharmaceuticals (IONS) to capitalize on its own developments, which is evidenced by the transition from licensing to independently launching drugs to ensure full profit retention.

Pesaing utama

TEM: Margin dodolan resik|Tingkat bathi miturut bathi resik Qiagen QGEN|Margin resik Repligen|Avidity (RNA) - Margin dodolan perusahaan|Margin dodolan resik CRSP|Margin dodolan perusahaan GeneDx|Margin resik Ultragenyx RARE|Margin dodolan perusahaan Beam Therapeutics (BEAM)|SRPT: Rentabilitas dodolan miturut bathi resik|Margin resik Twist Bioscience|TXG (10x Genomics) - Rentabilitas dodolan miturut bathi resik|Intellia Therapeutics, Inc. (NTLA) - Margin dodolan resik|Margin resik Stoke Therapeutics Inc|BLFS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik WVE (Wave Life Sciences Corp)|Margin dodolan perusahaan Maze Therapeutics Corp|Sionna Therapeutics Inc - Rentabilitas dodolan miturut bathi resik|PRME (primemedicine.com) - Margin bathi resik|TSHA - Margin resik|QURE (uniQure) - Rentabilitas dodolan resik|MeiraGTx Corp (MGTX) - Margin resik|Regenxbio - Tingkat bathi resik|Margin resik solidbio.com|Margin resik ocugen.com OCGN|Margin dodolan resik PACB|Benitec - Rentabilitas dodolan resik|Margin resik Design Therapeutics DSGN|Margin dodolan resik Rocket Pharmaceuticals RCKT|Margin bathi resik 4D Molecular Corp|LXEO: Margin resik|KRRO (Korro Bio, Inc) - Rentabilitas dodolan miturut bathi resik|Editas Medicine (EDIT) - Margin dodolan resik|Margin resik Silence Therapeutics Inc.|Rentabilitas dodolan resik PRQR (proqr.com)|Margin resik Codexis Bio (CDXS)|Margin dodolan resik sangamo.com (SGMO)|Margin resik nautilus.bio NAUT|Margin dodolan perusahaan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Margin dodolan resik|GBIO - Margin dodolan resik|BOLD: Margin dodolan resik|Rentabilitas dodolan resik XCUR|Margin resik Imunon|Phio Pharmaceuticals - Margin bathi resik|Margin resik Mustang Bio, Inc. (MBIO)|Margin dodolan perusahaan TransCode Therapeutics, Inc.|Margin resik Bionano Genomics BNGO|Tingkat bathi resik APDN|BLUE - Margin resik|Margin bathi resik IPA|Omega Therapeutics, Inc. (OMGA) - Margin resik|Singular Genomics Corp (OMIC) - Margin dodolan resik|RGLS (Regulus Therapeutics, Inc.) - Margin dodolan resik|SYRS: Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik TBIO (Telesis Bio Inc.)|Margin dodolan resik TRACON Pharmaceuticals Inc. (TCON)|Margin resik Unity Bio UBX